|
|
||||||||
, Plays a Major Role in Sustaining the Chronic Phase of Colitis in IL-10-Deficient Mice1

*
DNAX Research Institute of Cellular and Molecular Biology, Palo Alto, CA 94304; and
Schering-Plough Research Institute, Lafayette, NJ 07848
IL-10-deficient (IL-10-/-) mice develop chronic
enterocolitis mediated by CD4+ Th1 cells producing IFN-
.
Because IL-12 can promote Th1 development and IFN-
production, the
ability of neutralizing anti-IL-12 mAb to modulate colitis in
IL-10-/- mice was investigated. Anti-IL-12 mAb treatment
completely prevented disease development in young
IL-10-/- mice. Treatment of adult mice resulted in
significant amelioration of established disease accompanied by reduced
numbers of mesenteric lymph node and colonic CD4+ T cells
and of mesenteric lymph node T cells spontaneously producing IFN-
.
In contrast, anti-IFN-
mAb had minimal effect on disease
reversal, despite a significant preventative effect in young mice.
These findings suggested that IL-12 sustains colitis by supporting the
expansion of differentiated Th1 cells that mediate disease
independently of their IFN-
production. This conclusion was
supported by the finding that anti-IL-12 mAb greatly diminished the
ability of a limited number of CD4+ T cells expressing high
levels of CD45RB from diseased IL-10-/- mice to expand
and cause colitis in recombination-activating gene-2-/-
recipients, while anti-IFN-
mAb had no effect. Furthermore,
IL-12 could support pathogenic IL-10-/- T cells
stimulated in vitro in the absence of IL-2. While these studies show
that IL-12 plays an important role in sustaining activated Th1 cells
during the chronic phase of disease, the inability of anti-IL-12
mAb to abolish established colitis or completely prevent disease
transfer by Th1 cells suggests that additional factors contribute to
disease maintenance.
This article has been cited by other articles:
![]() |
J. Mane, E. Pedrosa, V. Loren, I. Ojanguren, L. Fluvia, E. Cabre, G. Rogler, and M. A. Gassull Partial Replacement of Dietary (n-6) Fatty Acids with Medium-Chain Triglycerides Decreases the Incidence of Spontaneous Colitis in Interleukin-10-Deficient Mice J. Nutr., March 1, 2009; 139(3): 603 - 610. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. V. Villarino, D. Artis, J. S. Bezbradica, O. Miller, C. J. M. Saris, S. Joyce, and C. A. Hunter IL-27R deficiency delays the onset of colitis and protects from helminth-induced pathology in a model of chronic IBD Int. Immunol., June 1, 2008; 20(6): 739 - 752. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. J. Albert and J. S. Marshall Aging in the absence of TLR2 is associated with reduced IFN-{gamma} responses in the large intestine and increased severity of induced colitis J. Leukoc. Biol., April 1, 2008; 83(4): 833 - 842. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Song, C. Matsuda, Y. Kai, T. Nishida, K. Nakajima, T. Mizushima, M. Kinoshita, T. Yasue, Y. Sawa, and T. Ito A Novel Sphingosine 1-Phosphate Receptor Agonist, 2-Amino-2-propanediol Hydrochloride (KRP-203), Regulates Chronic Colitis in Interleukin-10 Gene-Deficient Mice J. Pharmacol. Exp. Ther., January 1, 2008; 324(1): 276 - 283. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. Etling, S. Davies, M. Campbell, R. W. Redline, P. Fu, and A. D. Levine Maturation of the mucosal immune system underlies colitis susceptibility in interleukin-10-deficient (IL-10 / ) mice J. Leukoc. Biol., August 1, 2007; 82(2): 311 - 319. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Wada, R. Lu, D. Zhou, J. Chu, T. Przewloka, S. Zhang, L. Li, Y. Wu, J. Qin, V. Balasubramanyam, et al. Selective abrogation of Th1 response by STA-5326, a potent IL-12/IL-23 inhibitor Blood, February 1, 2007; 109(3): 1156 - 1164. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Kullberg, D. Jankovic, C. G. Feng, S. Hue, P. L. Gorelick, B. S. McKenzie, D. J. Cua, F. Powrie, A. W. Cheever, K. J. Maloy, et al. IL-23 plays a key role in Helicobacter hepaticus-induced T cell-dependent colitis J. Exp. Med., October 30, 2006; 203(11): 2485 - 2494. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Toichi, G. Torres, T. S. McCormick, T. Chang, M. A. Mascelli, C. L. Kauffman, N. Aria, A. B. Gottlieb, D. E. Everitt, B. Frederick, et al. An Anti-IL-12p40 Antibody Down-Regulates Type 1 Cytokines, Chemokines, and IL-12/IL-23 in Psoriasis J. Immunol., October 1, 2006; 177(7): 4917 - 4926. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Becker, H. Dornhoff, C. Neufert, M. C. Fantini, S. Wirtz, S. Huebner, A. Nikolaev, H.-A. Lehr, A. J. Murphy, D. M. Valenzuela, et al. Cutting Edge: IL-23 Cross-Regulates IL-12 Production in T Cell-Dependent Experimental Colitis. J. Immunol., September 1, 2006; 177(5): 2760 - 2764. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Hamano, A. Asgharpour, S. E. Stroup, T. A. Wynn, E. H. Leiter, and E. Houpt Resistance of C57BL/6 Mice to Amoebiasis Is Mediated by Nonhemopoietic Cells but Requires Hemopoietic IL-10 Production J. Immunol., July 15, 2006; 177(2): 1208 - 1213. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A.F. Hegazi, K. N. Rao, A. Mayle, A. R. Sepulveda, L. E. Otterbein, and S. E. Plevy Carbon monoxide ameliorates chronic murine colitis through a heme oxygenase 1-dependent pathway J. Exp. Med., December 19, 2005; 202(12): 1703 - 1713. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Kamada, T. Hisamatsu, S. Okamoto, T. Sato, K. Matsuoka, K. Arai, T. Nakai, A. Hasegawa, N. Inoue, N. Watanabe, et al. Abnormally Differentiated Subsets of Intestinal Macrophage Play a Key Role in Th1-Dominant Chronic Colitis through Excess Production of IL-12 and IL-23 in Response to Bacteria J. Immunol., November 15, 2005; 175(10): 6900 - 6908. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Hoentjen, R. B. Sartor, M. Ozaki, and C. Jobin STAT3 regulates NF-{kappa}B recruitment to the IL-12p40 promoter in dendritic cells Blood, January 15, 2005; 105(2): 689 - 696. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Van Kampen, J. Gauldie, and S. M. Collins Proinflammatory properties of IL-4 in the intestinal microenvironment Am J Physiol Gastrointest Liver Physiol, January 1, 2005; 288(1): G111 - G117. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Mannon, I. J. Fuss, L. Mayer, C. O. Elson, W. J. Sandborn, D. Present, B. Dolin, N. Goodman, C. Groden, R. L. Hornung, et al. Anti-Interleukin-12 Antibody for Active Crohn's Disease N. Engl. J. Med., November 11, 2004; 351(20): 2069 - 2079. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Blum, A. Metwali, D. E. Elliott, D. J. Berg, and J. V. Weinstock CD4+ T cells from IL-10-deficient mice transfer susceptibility to NSAID-induced Rag colitis Am J Physiol Gastrointest Liver Physiol, August 1, 2004; 287(2): G320 - G325. [Abstract] [Full Text] [PDF] |
||||
![]() |
B Sheil, J McCarthy, L O'Mahony, M W Bennett, P Ryan, J J Fitzgibbon, B Kiely, J K Collins, and F Shanahan Is the mucosal route of administration essential for probiotic function? Subcutaneous administration is associated with attenuation of murine colitis and arthritis Gut, May 1, 2004; 53(5): 694 - 700. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Liu, B. Hu, D. Xu, and F. Y. Liew CD4+CD25+ Regulatory T Cells Cure Murine Colitis: The Role of IL-10, TGF-{beta}, and CTLA4 J. Immunol., November 15, 2003; 171(10): 5012 - 5017. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. V. Weinstock, A. Blum, A. Metwali, D. Elliott, N. Bunnett, and R. Arsenescu Substance P Regulates Th1-Type Colitis in IL-10 Knockout Mice J. Immunol., October 1, 2003; 171(7): 3762 - 3767. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. P. Singh, S. Singh, D. D. Taub, and J. W. Lillard Jr. Inhibition of IFN-{gamma}-Inducible Protein-10 Abrogates Colitis in IL-10-/- Mice J. Immunol., August 1, 2003; 171(3): 1401 - 1406. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. F. Tomczak, S. E. Erdman, T. Poutahidis, A. B. Rogers, H. Holcombe, B. Plank, J. G. Fox, and B. H. Horwitz NF-{kappa}B Is Required Within the Innate Immune System to Inhibit Microflora-Induced Colitis and Expression of IL-12 p40 J. Immunol., August 1, 2003; 171(3): 1484 - 1492. [Abstract] [Full Text] [PDF] |
||||
![]() |
J McCarthy, L O'Mahony, L O'Callaghan, B Sheil, E E Vaughan, N Fitzsimons, J Fitzgibbon, G C O'Sullivan, B Kiely, J K Collins, et al. Double blind, placebo controlled trial of two probiotic strains in interleukin 10 knockout mice and mechanistic link with cytokine balance Gut, July 1, 2003; 52(7): 975 - 980. [Abstract] [Full Text] |
||||
![]() |
K. J. Myers, S. Murthy, A. Flanigan, D. R. Witchell, M. Butler, S. Murray, A. Siwkowski, D. Goodfellow, K. Madsen, and B. Baker Antisense Oligonucleotide Blockade of Tumor Necrosis Factor-alpha in Two Murine Models of Colitis J. Pharmacol. Exp. Ther., January 1, 2003; 304(1): 411 - 424. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Wille, E. N. Villegas, L. Craig, R. Peach, and C. A. Hunter Contribution of Interleukin-12 (IL-12) and the CD28/B7 and CD40/CD40 Ligand Pathways to the Development of a Pathological T-Cell Response in IL-10-Deficient Mice Infect. Immun., December 1, 2002; 70(12): 6940 - 6947. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Eyles, D. Metcalf, M. J. Grusby, D. J. Hilton, and R. Starr Negative Regulation of Interleukin-12 Signaling by Suppressor of Cytokine Signaling-1 J. Biol. Chem., November 8, 2002; 277(46): 43735 - 43740. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Iqbal, J. R. Oliver, F. H. Wagner, A. S. Lazenby, C. O. Elson, and C. T. Weaver T Helper 1 and T Helper 2 Cells Are Pathogenic in an Antigen-specific Model of Colitis J. Exp. Med., January 7, 2002; 195(1): 71 - 84. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Kullberg, A. G. Rothfuchs, D. Jankovic, P. Caspar, T. A. Wynn, P. L. Gorelick, A. W. Cheever, and A. Sher Helicobacter hepaticus-Induced Colitis in Interleukin-10-Deficient Mice: Cytokine Requirements for the Induction and Maintenance of Intestinal Inflammation Infect. Immun., July 1, 2001; 69(7): 4232 - 4241. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. O. Lindsay, C. J. Ciesielski, T. Scheinin, H. J. Hodgson, and F. M. Brennan The Prevention and Treatment of Murine Colitis Using Gene Therapy with Adenoviral Vectors Encoding IL-10 J. Immunol., June 15, 2001; 166(12): 7625 - 7633. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Hong, E. L. Berg, and R. O. Ehrhardt Persistence of Pathogenic CD4+ Th1-Like Cells In Vivo in the Absence of IL-12 but in the Presence of Autoantigen J. Immunol., April 1, 2001; 166(7): 4765 - 4772. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Annacker, R. Pimenta-Araujo, O. Burlen-Defranoux, T. C. Barbosa, A. Cumano, and A. Bandeira CD25+ CD4+ T Cells Regulate the Expansion of Peripheral CD4 T Cells Through the Production of IL-10 J. Immunol., March 1, 2001; 166(5): 3008 - 3018. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Fort, R. Lesley, N. J. Davidson, S. Menon, F. Brombacher, M. W. Leach, and D. M. Rennick IL-4 Exacerbates Disease in a Th1 Cell Transfer Model of Colitis J. Immunol., February 15, 2001; 166(4): 2793 - 2800. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. A. Dieleman, A. Arends, S. L. Tonkonogy, M. S. Goerres, D. W. Craft, W. Grenther, R. K. Sellon, E. Balish, and R. B. Sartor Helicobacter hepaticus Does Not Induce or Potentiate Colitis in Interleukin-10-Deficient Mice Infect. Immun., September 1, 2000; 68(9): 5107 - 5113. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Cong, C. T. Weaver, A. Lazenby, and C. O. Elson Colitis Induced by Enteric Bacterial Antigen-Specific CD4+ T Cells Requires CD40-CD40 Ligand Interactions for a Sustained Increase in Mucosal IL-12 J. Immunol., August 15, 2000; 165(4): 2173 - 2182. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. M. Wittig, B. Johansson, M. Zoller, C. Schwarzler, and U. Gunthert Abrogation of Experimental Colitis Correlates with Increased Apoptosis in Mice Deficient for Cd44 Variant Exon 7 (Cd44v7) J. Exp. Med., June 19, 2000; 191(12): 2053 - 2064. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Rennick and M. M. Fort Lessons From Genetically Engineered Animal Models: XII. IL-10-deficient (IL-10-/-) mice and intestinal inflammation Am J Physiol Gastrointest Liver Physiol, June 1, 2000; 278(6): G829 - G833. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. I. Karachunski, N. S. Ostlie, C. Monfardini, and B. M. Conti-Fine Absence of IFN-{gamma} or IL-12 Has Different Effects on Experimental Myasthenia Gravis in C57BL/6 Mice J. Immunol., May 15, 2000; 164(10): 5236 - 5244. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kawachi, S. Jennings, J. Panes, A. Cockrell, F. S. Laroux, L. Gray, M. Perry, H. van der Heyde, E. Balish, D. N. Granger, et al. Cytokine and endothelial cell adhesion molecule expression in interleukin-10-deficient mice Am J Physiol Gastrointest Liver Physiol, May 1, 2000; 278(5): G734 - G743. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Naiki, H. Nishimura, T. Kawano, Y. Tanaka, S. Itohara, M. Taniguchi, and Y. Yoshikai Regulatory Role of Peritoneal NK1.1+{alpha}{beta} T Cells in IL-12 Production During Salmonella Infection J. Immunol., August 15, 1999; 163(4): 2057 - 2063. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Hong, A. Chu, B. R. Ludviksson, E. L. Berg, and R. O. Ehrhardt IL-12, Independently of IFN-{gamma}, Plays a Crucial Role in the Pathogenesis of a Murine Psoriasis-Like Skin Disorder J. Immunol., June 15, 1999; 162(12): 7480 - 7491. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Schultz, S. L. Tonkonogy, R. K. Sellon, C. Veltkamp, V. L. Godfrey, J. Kwon, W. B. Grenther, E. Balish, I. Horak, and R. B. Sartor IL-2-deficient mice raised under germfree conditions develop delayed mild focal intestinal inflammation Am J Physiol Gastrointest Liver Physiol, June 1, 1999; 276(6): G1461 - G1472. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. T. Chang, E. M. Shevach, and B. M. Segal Regulation of Interleukin (IL)-12 Receptor {beta}2 Subunit Expression by Endogenous IL-12: A Critical Step in the Differentiation of Pathogenic Autoreactive T Cells J. Exp. Med., March 15, 1999; 189(6): 969 - 978. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. W. Leach, N. J. Davidson, M. M. Fort, F. Powrie, and D. M. Rennick The Role of IL-10 in Inflammatory Bowel Disease: "Of Mice and Men" Toxicol Pathol, January 1, 1999; 27(1): 123 - 133. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |